Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Port-a-caths in cancer patients

C L Sinoff1, T Koski

  • 1Northeastern Ontario Regional Cancer Centre, Sudbury, Canada.

South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|June 1, 1993
PubMed
Summary

Implanted vascular ports (Port-a-caths) offer useful vascular access for cancer patients, with a low complication rate. However, serious complications, though rare, necessitate careful consideration before device insertion.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Classification of <i>Enterobacteriaceae</i> by minimization of stochastic complexity.

Microbiology (Reading, England)·2021
Same author

Von Willebrand disease in Finland.

Haemophilia : the official journal of the World Federation of Hemophilia·2013
Same author

Haemovigilance for the optimal use of blood products in the hospital.

Vox sanguinis·2010
Same author

Prevention and diagnosis of delayed haemolytic transfusion reactions.

Vox sanguinis·2006
Same author

Spinal cord compression in beta-thalassemia: case report and review of the literature.

Spinal cord·2004
Same author

A fragment library based on Gaussian mixtures predicting favorable molecular interactions.

Journal of molecular biology·2001

Area of Science:

  • Oncology
  • Vascular Surgery
  • Medical Devices

Background:

  • Implanted vascular access devices, specifically Port-a-caths, are frequently utilized in cancer patients for long-term therapy.
  • Evaluating the safety and efficacy of these devices is crucial for patient management and treatment protocols.

Observation:

  • A total of 89 venous and 4 hepatic arterial Port-a-caths were inserted in 91 cancer patients, with a follow-up of up to 33 months (1,525 patient-months).
  • Complications occurred in 18 patients, including 1 fatal, 9 serious, and 8 minor events.
  • Infection was a rare complication, while younger patient age was associated with a higher incidence of complications.

Findings:

  • Port-a-caths demonstrate significant utility for vascular access in oncology patients.
  • The overall complication rate associated with Port-a-cath insertion is low.
  • A small but significant risk of serious and fatal complications exists.

Implications:

  • The judicious selection of patients for Port-a-cath insertion is recommended due to the potential for severe adverse events.
  • Further research into risk factors, such as patient age, may optimize the use of these vascular access devices.
  • Continued monitoring and reporting of complications are essential for refining clinical practice guidelines.

Related Experiment Videos